Maynilad Water Services has hired banks including Morgan Stanley and UBS to work on a more than $500 million initial public ...
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
Financial analysis of American National Group's preferred stock ANG-D reveals concerns about dividend payments and market ...
For investors, this sharp contrast with the broader market could be seen as a sign of strong potential. While the S&P 500 is showing moderate growth, DGNX’s surge reflects strong investor enthusiasm, ...
Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...
Travel data provider Hopper Inc., one of Canada’s largest closely held technology companies, is eyeing a public listing that ...
Sunway Bhd. plans to start the initial public offering process for its hospital assets early next month, which would value ...
A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
A strong U.S. economy and lower interest rates could foster a surge in the number of initial public offerings in 2025, ...